(Q64355658)
Statements
ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease (English)
D J Stone
C Molony
E E Schadt
8 December 2009
scientific article published on 08 December 2009
No description defined